4-(2-bromo-5-fluorobenzyl)piperidine | 286469-95-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-(2-bromo-5-fluorobenzyl)piperidine
• 英文别名: 4-[(2-Bromo-5-fluorophenyl)methyl]piperidine
• CAS: 286469-95-2
• 化学式: C₁₂H₁₅BrFN
• 分子量: 272.16
• InChiKey: YSHDUSYXUHYLCF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(2-bromo-5-fluorobenzyl)piperidine 、 8'H-spiro[cyclohexane-1,6'-[1,3]dioxolo[4,5-e]isobenzofuran]-4,8'-dione 在 titanium(IV) isopropylate 、 sodium tetrahydroborate 作用下， 以 乙醇 为溶剂， 以18%的产率得到
  参考文献：
  名称：

  Ligand conformation has a definitive effect on 5-HT1A and serotonin reuptake affinity

  摘要：

  Conformationally constrained aryl cyclohexanes and cyclohexenes based on aryl cyclohexanols 1 were prepared. Locking the aryl ring in plane with the cyclohexane moiety provided potent SSRIs 3. Conversely, fixing the aryl ring perpendicular to the cyclohexane ring via a spiro lactone provided balanced 5-HT1A antagonists with mid-nanomolar range SSRI potency (compounds 2). (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.06.050

文献信息

• Antidepressant heterocyclic compounds
  申请人：Bristol-Myers Squibb Company

  公开号：US06225324B1

  公开（公告）日：2001-05-01

  Compounds of formula I are useful antidepressant agents demonstrating potent inhibition of 5-HT reuptake. Z is selected from among various phenyl and hetaryl moieties while Y is benzyl or indolyl.

  式I的化合物是有用的抗抑郁药物，表现出对5-HT再摄取的强效抑制作用。Z从各种苯基和杂环基团中选择，而Y是苄基或吲哚基。
• Antipsychotic heterocycle compounds
  申请人：——

  公开号：US20020072611A1

  公开（公告）日：2002-06-13

  Compounds of Formula I are useful antipsychotic and antidepressant agents demonstrating potent inhibition of 5-HT reuptake and dopamine D2 receptor antagonism. Ar—Y—(CH 2 ) m —Z   I In Formula I: Ar is selected from 1 Z is II or III; 2 Y is sulfur or oxygen; R 1 and R 4 are independently selected from H and lower alkyl; R 2 , R 3 , R 6 and R 7 are independently selected from H, halogen, and lower alkoxy; R 5 is selected from H, halogen, lower alkoxy and cyano; m is an integer from 2-6; n is zero or the integer 1 or 2; and a dotted line represents an optional double bond.

  式I的化合物是有用的抗精神病和抗抑郁药物，表现出对5-HT再摄取和多巴胺D2受体的强效抑制作用。Ar—Y—(CH2)m—Z 在式I中：Ar从1中选择Z为II或III；2Y为硫或氧；R1和R4分别选择自H和较低的烷基；R2、R3、R6和R7分别选择自H、卤素和较低的烷氧基；R5从H、卤素、较低的烷氧基和氰基中选择；m为2-6之间的整数；n为零或整数1或2；虚线代表可选的双键。
• Serotonin reuptake inhibitor
  申请人：SUMITOMO PHARMACEUTICALS COMPANY LIMITED

  公开号：US20030191126A1

  公开（公告）日：2003-10-09

  A serotonin reuptake inhibitor containing a cyclic amine represented by the following formula, a prodrug thereof, or a pharmaceutically acceptable salt of said cyclic amine or prodrug as an active ingredient: 1 wherein R 0 is a hydrogen atom, a halogen atom, an alkyl group, a substituted alkyl group, a hydroxyl group, an alkoxy group or the like, R 3 is a hydrogen atom or the like, Y is an alkylene group or the like, Z is a hydrogen atom, a cycloalkyl group, an aryl group or the like, n is 1, 2 or 3, and m is 2, 3, 4, 5 or 6.

  一种含有下列公式所代表的环胺的5-羟色胺再摄取抑制剂，其前药，或所述环胺或前药的药用可接受的盐作为活性成分：其中R0是氢原子、卤原子、烷基、取代烷基、羟基、烷氧基或类似物，R3是氢原子或类似物，Y是烷基或类似物，Z是氢原子、环烷基、芳基或类似物，n为1、2或3，m为2、3、4、5或6。
• SEROTONIN REUPTAKE INHIBITORS
  申请人：Sumitomo Pharmaceuticals Company, Limited

  公开号：EP1304324A1

  公开（公告）日：2003-04-23

  A serotonin reuptake inhibitor containing a cyclic amine represented by the following formula, a prodrug thereof, or a pharmaceutically acceptable salt of said cyclic amine or prodrug as an active ingredient: wherein R0 is a hydrogen atom, a halogen atom, an alkyl group, a substituted alkyl group, a hydroxyl group, an alkoxy group or the like, R3 is a hydrogen atom or the like, Y is an alkylene group or the like, Z is a hydrogen atom, a cycloalkyl group, an aryl group or the like, n is 1, 2 or 3, and m is 2, 3, 4, 5 or 6.

  一种血清素再摄取抑制剂，其活性成分含有下式所代表的环胺、其原药或所述环胺或原药的药学上可接受的盐： 其中 R0 是氢原子、卤素原子、烷基、取代烷基、羟基、烷氧基或类似物，R3 是氢原子或类似物，Y 是亚烷基或类似物，Z 是氢原子、环烷基、芳基或类似物，n 是 1、2 或 3，m 是 2、3、4、5 或 6。
• ANTIDEPRESSANT HETEROCYCLIC COMPOUNDS
  申请人：Bristol-Myers Squibb Company

  公开号：EP1146871A1

  公开（公告）日：2001-10-24